Skip to main content
FinSpry Logo
FinSpry
CNTB logo
CNTB
(NASDAQ)
Connect Biopharma Holdings Limited
$2.07-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Connect Biopharma Holdings Limited (CNTB) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Connect Biopharma Holdings Limited stock.

Analyst Consensus Rating

Investment consensus from 6 professional research analysts

Consensus Rating

Buy
Based on 6 unique analysts
(9 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$7.25
↑ 250.24% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest CNTB Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Edward Nash
Canaccord Genuity
BuyInitiates
$6.00
Brandon Folkes
HC Wainwright
BuyReiterates
$7.00
Olivia Brayer
Cantor Fitzgerald
BuyInitiates
$4.00
Julian Harrison
BTIG
BuyMaintains
$10.00
Carl Byrnes
Northland
BuyMaintains
$7.50
Thomas Flaten
Lake Street
BuyMaintains
$9.00
Julian Harrison
BTIG
Strong BuyReiterates
$10.00 → $10.00
Julian Harrison
BTIG
Strong BuyReiterates
$10.00 → $10.00
Thomas Flaten
Lake Street
BuyMaintains
$9.00

Frequently Asked Questions

What is the analyst consensus rating for CNTB?

The analyst consensus rating for CNTB is "Buy" based on 6 analyst recommendations.

What is the average price target for CNTB?

The average 12-month price target for CNTB is $7.25, representing an upside of 250.2% from the current price of $2.07.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.